Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Editas Medicine
(NQ:
EDIT
)
4.000
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Editas Medicine
< Previous
1
2
3
4
5
6
7
8
9
Next >
Gene Editing Stocks: The Trial News Lifting NTLA, CRSP and EDIT Stocks Today
August 23, 2021
Today, gene editing stocks are getting a big boost after an intriguing data release by Editas for the company's new SLEEK technology.
Via
InvestorPlace
35 Stocks Moving In Monday's Mid-Day Session
August 23, 2021
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...
Via
Benzinga
25 Stocks Moving in Monday's Pre-Market Session
August 23, 2021
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...
Via
Benzinga
Editas Medicine Unveils Preclinical Data From New Gene Editing Technology
August 23, 2021
Editas Medicine Inc (NASDAQ: EDIT) announced data on a new gene-editing technology termed SLEEK (SeLection by Essential-gene Exon Knock-in). Data were...
Via
Benzinga
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
Editas could be an attractive acquisition candidate for the big vaccine maker.
Via
The Motley Fool
Why Editas Medicine Beat the Market on Monday
August 09, 2021
Another analyst ups his recommendation on the stock.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021
August 09, 2021
Upgrades DA Davidson upgraded the previous rating for AAON Inc (NASDAQ:
Via
Benzinga
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
Gene Editing Stocks: Why EDIT, NTLA, CRSP Stocks Are Climbing Today
August 05, 2021
Today, investors in gene editing stocks are seeing a lot of green as earnings were announced along with business updates from key players.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
August 05, 2021
Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Thursday
August 05, 2021
Keybanc boosted the price target for HubSpot, Inc. (NYSE:
Via
Benzinga
Editas Medicine, inc (EDIT) Q2 2021 Earnings Call Transcript
August 04, 2021
EDIT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Editas Medicine Stock Shows Improved Relative Strength Rating
July 22, 2021
A Relative Strength Rating upgrade for Editas Medicine shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Editas Stock Isn’t Worth Buying This Early Into Treatment Development
July 21, 2021
EDIT stock is part of a pioneering movement in CRISPR gene editing, but there's no way to know whether the company will succeed long term.
Via
InvestorPlace
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
July 16, 2021
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
Via
The Motley Fool
After Game-Changing Clinical Trial Results, These 2 Cathie Wood Stocks Are Exploding
July 15, 2021
It's a good time to be a gene-editing company.
Via
The Motley Fool
WHO Issues Framework For Governance For Gene Editing Technologies
July 12, 2021
A World Health Organization expert advisory panel Monday issued two new reports recommending the implementation of global standards to prevent future unsafe or...
Via
Benzinga
A Comprehensive Guide To Genomic ETFs
July 11, 2021
Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon...
Via
Talk Markets
Is It Too Late to Buy Intellia Therapeutics?
July 10, 2021
After skyrocketing 68% last week, will this stock keep running higher?
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) shares increased by 43.13% to $0.68 during Tuesday's regular session. The current volume of 106.3 million shares is 1084.49% of Advaxis...
Via
Benzinga
Here's What Drove Gene Editing Stocks Higher This Week
July 02, 2021
The most exciting clinical trial data in the medical community has huge implications for Intellia, and its peers.
Via
The Motley Fool
Unusual Options Activity Insight: Editas Medicine
July 01, 2021
Shares of Editas Medicine (NASDAQ:EDIT) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $53.28. Sentiment:...
Via
Benzinga
72 Biggest Movers From Yesterday
July 01, 2021
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Gene Editing Stocks: Why EDIT, CRSP, NTLA Stocks Continue to Soar
June 30, 2021
Today, gene editing stocks are soaring amid increasingly bullish sentiment in this sector following strong results from Intellia.
Via
InvestorPlace
Why Gene Editing Stocks Are Trading Higher Again Today
June 30, 2021
Shares of gene editing stocks are continuing higher in sympathy with peer company Intellia (NASDAQ: NTLA), which gained in recent sessions following positive data for its...
Via
Benzinga
51 Stocks Moving In Wednesday's Mid-Day Session
June 30, 2021
Gainers Cuentas Inc. (NASDAQ: CUEN) shares jumped 176.6% to $7.69. The stock spiked following a press release saying "WaveMax to Implement the World's First Shared Wifi6...
Via
Benzinga
Why Editas Medicine Stock Is Jumping Today
June 28, 2021
Good news for Intellia was viewed as good news for Editas.
Via
The Motley Fool
Intellia Stock Leads Biotech Rally On Historic Moment For CRISPR
June 28, 2021
Intellia led a rally for CRISPR stocks on Monday on early promise for its gene-editing drug. The news sent NTLA stock to a record high.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 28, 2021
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 62.0% to $143.91 during Monday's pre-market session. The company's market cap stands at $9.8 billion....
Via
Benzinga
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks
June 28, 2021
Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.